US3276448A - Collagen coated fabric prosthesis - Google Patents

Collagen coated fabric prosthesis Download PDF

Info

Publication number
US3276448A
US3276448A US244600A US24460062A US3276448A US 3276448 A US3276448 A US 3276448A US 244600 A US244600 A US 244600A US 24460062 A US24460062 A US 24460062A US 3276448 A US3276448 A US 3276448A
Authority
US
United States
Prior art keywords
collagen
fabric
prosthesis
mesh
coated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US244600A
Inventor
Richard L Kronenthal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethicon Inc
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Priority to US244600A priority Critical patent/US3276448A/en
Priority to GB49207/63A priority patent/GB1062876A/en
Priority to SE13929/63A priority patent/SE314159B/xx
Application granted granted Critical
Publication of US3276448A publication Critical patent/US3276448A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063Implantable repair or support meshes, e.g. hernia meshes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/92Method or apparatus for preparing or treating prosthetic
    • Y10S623/921Blood vessel

Definitions

  • This invention relates to prostheses adapted to be placed in the human body, and to a process for manufacturing the same. More particularly, the invention is directed to prostheses formed of porous, non-absorbable fabric coated with collagen.
  • Tendon collagen fibril means a thread-like collagen structure derived from beef tendon that is round in cross section. These fibrils in the completely dehydrated state measure about 500 to 2000 Angstroms in diameter.
  • Swollen tendon collagen fibril means a collagen fibril derived from beef tendon that has been swollen in acid solution.
  • the diameters of swollen collagen fibrils range from less than 5000 Angstroms to about 90,000 Angstroms.
  • Monofilament means a single thread of oriented collagen fibrils as extruded through a single orifice in a spinnerette.
  • Multifilament means a group :of individual separate collagen monofilaments extruded through a spinnerette. Further details are provided in related copending application Serial No. 216,247, filed August 10, 1962, and in Example XII of U.S. Patent No. 3,114,372.
  • Strand means a group of collagen monofilaments that have been united to form a unitary structure.
  • Tape means a group of individual collagen monofilaments that have been united to form a unitary structure that is ribbon-like in shape.
  • Non-absorbable fibers means those fibers, synthetic or natural, which are not absorbed in an animal body, particularly a human body, when present therein over an extended period of time.
  • a non-absorbable fabric is a fabric formed of non-absorbable fibers.
  • Associations of collagen and non-absorbable fibers means a combination of collagen filaments or strands and one or more non-absorbable fibers, formed by iweaving, knitting, braiding, crocheting, etc. the filaments or strands and fibers together into articles including tubes, which can be straight or Y-shaped.
  • tantalum gauze and inert fabrics have found considerable use, particularly in older patients who are recognized to have a reduced ability to rebuild tissue at the point of surgery. Tantalum gauze, however, has the undesirable property of work hardening and can curl up within the body, causing discomfort.
  • Inert fabric prostheses have the disadvantage that they do not become a part of the body tissue. During surgery, some surgeons have tried to overcome this disadvantage by knotting catgut sutures randomly throughout the fabric prosthesis. However, this does not result in a uniformly integrated fabric prosthesis. Many intert fabric inserts frequently remain surrounded by a pool of sera after the healing process.
  • a suitable prosthesis for strengthening the repair should be non-toxic, flexible and porous. The ideal prosthesis should retain its strength permanently in intimate contact with body fluids and should be readily accepted and incorporated into the tissues. Porosity is an important characteristic of such a prosthesis to avoid the formation of fluid pockets and to promote the growth through the fabric of repair tissue.
  • a primary object of the invention is to provide a porous, non-absorbable fabric compatible with an animal body, and coated with collagen.
  • a further object is to provide a porous, non-absorbable fabric which is coated with collagen and the pores of which are free of collagen.
  • Another object is the provision of prostheses comprised of the fabric so coated with collagen and promoting the growth of body tissue into and through the prostheses during the healing process.
  • Still another object is the provision of a process for manufacturing the prostheses of this invention. And another object is the provision of a process for pretreating the fabric in the manufacture of the prostheses.
  • an improved prostheses comprised of a porous, non-absorbable fabric coated with collagen, the pores of the fabric being free of collagen. It is an essential feature of the new prostheses that the pores thereof are open and not rendered blood tight by collagen fibrils. In this regard, they are distinct fromthose described by Artandi and Bechtol in related application Serial No. 92,620, filed March 1, 1961 (now abandoned), and application Serial No. 495,010 filed September 22, 1965.
  • the prostheses of this invention are formed by knitting, weaving, braiding, crocheting, etc. non-absorbable fibers into the shape or form desired.
  • the fibers are not absorbed by an animal body, as the human body, when present therein over extended time intervals, such as a decade.
  • Suitable materials are Vinyon-N, a resin manufactured by the Carbide and Carbon Corporation by copolymerizing vinyl chloride and acrylonitrile; Saran, a vinyl chloride polymer manufactured by the Dow Chemical Company; nylon, a polyamide resin made by polymerization of the hexamethylene diamine salt of adipic acid; Orlon, a synthetic fiber made from polyacrylonitrile; Dacron, a synthetic fiber made from terephthalic acid and ethylene glycol; Teflon, a tetrafluoroethylene polymer; polyolefins such as polyethylene and polypropylene; cotton and silk.
  • Nylon, Orlon, Dacron and Teflon are products of the E. I. du Pont de Nemours 8: Co. Preferred herein are Dacron, Teflon and polyolefins.
  • non-absorbable fibers used herein can be knitted, woven, braided, crocheted, etc. into forms suitable for porous implants, in any manner known in the art, since such does not form a part of this invention.
  • Collagen used herein to coat the non-absorbable fabric corresponds to the type of connective tissue normally laid down by the body during the healing process.
  • the collagen coating serves as a stimulus for body response during the post-operative period.
  • the porous character of the fabric allows for rapid in-growth of fibroblasts and endothelial cells. All such features combine in concert to make possible rapid and satisfactory attachment of the prosthesis to the host tissues.
  • Collagen can be prepared as described in United States Patent No. 2,920,000 of H. R. Hoohstadt and E. R. Lieberman. Since it is diflicult to prepare a collagen dispersion containing more than 2 percent collagen because of ex tremely high viscosities of more concentrated dispersions, the collagen dispersions used in this invention generally contain from 0.1 to 2 percent by weight of collagen.
  • the vehicle or liquid containing collagen can be one of a wide variety of materials, including: alcohols such as methanol; aqueous solutions of perfluoroacids, as shown in US. Patent Nos. 2,919,998 and 2,919,999; and aqueous cyanoacetic acid. Particularly preferred herein are collagen dispersions in a mixture of methanol and aqueous cyanoacetic acid.
  • the non-absorbable fabric as in film or mesh form, can be coated with collagen by a number of techniques.
  • the fabric can be immersed in a collagen dispersion for a suitable period of time, and the fabric can then be removed and allowed to drain and dry. Collagen is neutralized after the coated fabric is dry.
  • a dispersion of collagen can be sprayed onto the fabric, followed by draining of the sprayed fabric.
  • the fabric When the fabric is immersed in a collagen dispersion, the fabric is coated with collagen and is thereafter treated to remove collagen present in the pores thereof. This is accomplished advantageously by directing a stream of inert gas against the coated fabric, particularly through the coated fabric. The stream is so adjusted that collagen held in the pores of the coated fabric is removed, while collagen coating the fabric structure is retained. There is little danger that the collagen coat will be removed from the fabric, since a relatively strong bonding of collagen and the fabric obtains.
  • inert gases useful herein are air, nitrogen, and carbon dioxide. Since air is inexpensive and advantageous, it is preferred.
  • a fabric treated with collagen can be dried and then perforated to remove collagen from the pores thereof.
  • Temperatures of the impregnation step, draining (if such is used), neutralization and removal of collagen from the pores, are generally below about C. in each operation to avoid extensive degradation of collagen. Preferred for each operation are temperatures below about 25 C.
  • tanning agents for use with collagen can be used herein. Chromium, formaldehyde, polyhydroxyphenols, etc. can be used alone or in combination. Particularly preferred, however, are the tanning procedures described in related applications Serial Numbers 85,289 and 85,302, both filed January 27, 1961.
  • Solvents falling within category (A) include water and dilute aqueous solutions containing a detergent, among which are sulfates such as sodium lauryl sulfate, sulfonates such as sodium dodecyl benzene sulfonate, phosphates such as sodium tripolyphosphate, polyoxyalkylene derivatives of a hydroxy compound such as a condensate of 1 mol of nonyl phenol with 9 mols of ethylene oxide, quarternary ammonium compounds such as cetyltrimethylammonium chloride, etc.
  • a detergent among which are sulfates such as sodium lauryl sulfate, sulfonates such as sodium dodecyl benzene sulfonate, phosphates such as sodium tripolyphosphate, polyoxyalkylene derivatives of a hydroxy compound such as a condensate of 1 mol of nonyl phenol with 9 mols of ethylene oxide, quarternary am
  • solvents (B) are: alcohols, typified by methyl, ethyl, n-propyl, isopropyl, n-butyl, secondaryand tertiary-butyl, etc.; ketones, typified by acetone, methyl ethyl, methyl n-propyl, diethyl, etc.; ethers, typified by dimethyl, diethyl, ethyl methyl, etc.
  • Pretreatment is conducted at temperatures from about C. to about 100 C., for time intervals ranging from about 60 minutes to about 1 minute with each solvent, (A) and (B); preferred conditions are the approximate ranges of 6070 C., for 10-5 minutes.
  • Example I 4.33 grams of Dacron mesh (40 denier multifilament Dacron 12.5 inch square) was immersed in a gel prepared by diluting a collagen dispersion comprising 0.8 part of collagen, 0.4 part cyanoacetic acid, 49.4 parts water and 49.4 parts of methyl alcohol with an equal volume of methyl alcohol at room temperature (20 C.). The mesh was removed from the dispersion and allowed to drain vertically for about five minutes at room temperature. Compressed air was blown through the mesh to remove any collagenous film remaining across the interstices. If the orifice pressure is about 20 lbs. and the orifice is 4 mm. in diameter, a distance of approximately 3" between the orifice and the mesh is advantageous. Using the same orifice at 35 lbs.
  • Example II A piece of Dacron mesh (the same size and Weight as in Example I) was washed successively with 100 parts of hot water (60 C.), with 100 parts of isopropyl alcohol (25 C.) and 100 parts of acetone (25 C.). It was then dried in the air. The dried mesh was placed in a stainless-steel, Teflon coated tray measuring 15" x 9" x /2" containing a A;" layer of collagen dispersion containing 0.8 part of collagen fibrils and 49.4 parts of methyl alcohol, and 49.4 parts of water and 0.4 part of cyanoacetic acid, and another A2" layer of the same dispersion was placed on top of the fabric. The collagen dispersions and mesh were in contact for 24 hours at 25 C.
  • the resulting laminate then was neutralized with 100 parts of 10 percent aqueous ammonia. It was tanned with 100 parts of formaldehyde (1 percent) and removed from the tray. Edges of the mesh were trimmed to remove excess collagen. The laminate was strong, uniform and very resistant to separation. These characteristics continued when the film was wet with water. Only very severe stretching or deformation freed an edge of the collagen from the Dacron mesh and, once freed, it resisted further delarnination.
  • Dacron and collagen are more firmly bound by virtue of the pretreatment of Dacron, than when the pretreatment is omitted. In fact, pretreated Dacron and collagen are more firmly bound than when brought together by any other technique.
  • a surgical prosthesis comprising:
  • said fibers being coated with collagen fibrils throughout their area of contact only, whereby the pores 5 of the fabric are open to the rapid ingrowth of body tissue through the prosthesis.
  • porous fabric is a synthetic material made from terephthalic acid and ethylene glycol.
  • porous fabric is a synthetic material made of a tetrafluoroethylene polymer.

Description

United States Patent 3,276,448 COLLAGEN COATED FABRIC PROSTHESIS Richard L. Kronenthal, Fair Lawn, N.J., assiguor to Ethicon, Inc., Somerville, N.J., a corporation of New Jersey No Drawing. Filed Dec. 14, 1962, Ser. No. 244,600 4 Claims. (Cl. 128-334) This invention relates to prostheses adapted to be placed in the human body, and to a process for manufacturing the same. More particularly, the invention is directed to prostheses formed of porous, non-absorbable fabric coated with collagen.
For purposes of clarity, the terms used herein are defined as follows:
Tendon collagen fibril means a thread-like collagen structure derived from beef tendon that is round in cross section. These fibrils in the completely dehydrated state measure about 500 to 2000 Angstroms in diameter.
Swollen tendon collagen fibril means a collagen fibril derived from beef tendon that has been swollen in acid solution. The diameters of swollen collagen fibrils range from less than 5000 Angstroms to about 90,000 Angstroms.
Monofilament means a single thread of oriented collagen fibrils as extruded through a single orifice in a spinnerette.
Multifilament means a group :of individual separate collagen monofilaments extruded through a spinnerette. Further details are provided in related copending application Serial No. 216,247, filed August 10, 1962, and in Example XII of U.S. Patent No. 3,114,372.
Strand means a group of collagen monofilaments that have been united to form a unitary structure.
Tape means a group of individual collagen monofilaments that have been united to form a unitary structure that is ribbon-like in shape.
Non-absorbable fibers means those fibers, synthetic or natural, which are not absorbed in an animal body, particularly a human body, when present therein over an extended period of time. A non-absorbable fabric is a fabric formed of non-absorbable fibers.
Associations of collagen and non-absorbable fibers means a combination of collagen filaments or strands and one or more non-absorbable fibers, formed by iweaving, knitting, braiding, crocheting, etc. the filaments or strands and fibers together into articles including tubes, which can be straight or Y-shaped.
In the surgical repair of hernias, tantalum gauze and inert fabrics have found considerable use, particularly in older patients who are recognized to have a reduced ability to rebuild tissue at the point of surgery. Tantalum gauze, however, has the undesirable property of work hardening and can curl up within the body, causing discomfort. Inert fabric prostheses have the disadvantage that they do not become a part of the body tissue. During surgery, some surgeons have tried to overcome this disadvantage by knotting catgut sutures randomly throughout the fabric prosthesis. However, this does not result in a uniformly integrated fabric prosthesis. Many intert fabric inserts frequently remain surrounded by a pool of sera after the healing process. A suitable prosthesis for strengthening the repair should be non-toxic, flexible and porous. The ideal prosthesis should retain its strength permanently in intimate contact with body fluids and should be readily accepted and incorporated into the tissues. Porosity is an important characteristic of such a prosthesis to avoid the formation of fluid pockets and to promote the growth through the fabric of repair tissue.
3,276,448 Patented Oct. 4, 1966 A primary object of the invention, therefore, is to provide a porous, non-absorbable fabric compatible with an animal body, and coated with collagen. A further object is to provide a porous, non-absorbable fabric which is coated with collagen and the pores of which are free of collagen. Another object is the provision of prostheses comprised of the fabric so coated with collagen and promoting the growth of body tissue into and through the prostheses during the healing process.
Still another object is the provision of a process for manufacturing the prostheses of this invention. And another object is the provision of a process for pretreating the fabric in the manufacture of the prostheses.
Additional objects will be apparent from the following discussion.
The foregoing objects are realized with an improved prostheses comprised of a porous, non-absorbable fabric coated with collagen, the pores of the fabric being free of collagen. It is an essential feature of the new prostheses that the pores thereof are open and not rendered blood tight by collagen fibrils. In this regard, they are distinct fromthose described by Artandi and Bechtol in related application Serial No. 92,620, filed March 1, 1961 (now abandoned), and application Serial No. 495,010 filed September 22, 1965.
The prostheses of this invention are formed by knitting, weaving, braiding, crocheting, etc. non-absorbable fibers into the shape or form desired. The fibers are not absorbed by an animal body, as the human body, when present therein over extended time intervals, such as a decade. Examples of suitable materials are Vinyon-N, a resin manufactured by the Carbide and Carbon Corporation by copolymerizing vinyl chloride and acrylonitrile; Saran, a vinyl chloride polymer manufactured by the Dow Chemical Company; nylon, a polyamide resin made by polymerization of the hexamethylene diamine salt of adipic acid; Orlon, a synthetic fiber made from polyacrylonitrile; Dacron, a synthetic fiber made from terephthalic acid and ethylene glycol; Teflon, a tetrafluoroethylene polymer; polyolefins such as polyethylene and polypropylene; cotton and silk. Nylon, Orlon, Dacron and Teflon are products of the E. I. du Pont de Nemours 8: Co. Preferred herein are Dacron, Teflon and polyolefins.
It is to be understood that the non-absorbable fibers used herein can be knitted, woven, braided, crocheted, etc. into forms suitable for porous implants, in any manner known in the art, since such does not form a part of this invention.
Collagen used herein to coat the non-absorbable fabric corresponds to the type of connective tissue normally laid down by the body during the healing process. Thus, the collagen coating serves as a stimulus for body response during the post-operative period. The porous character of the fabric allows for rapid in-growth of fibroblasts and endothelial cells. All such features combine in concert to make possible rapid and satisfactory attachment of the prosthesis to the host tissues.
Collagen can be prepared as described in United States Patent No. 2,920,000 of H. R. Hoohstadt and E. R. Lieberman. Since it is diflicult to prepare a collagen dispersion containing more than 2 percent collagen because of ex tremely high viscosities of more concentrated dispersions, the collagen dispersions used in this invention generally contain from 0.1 to 2 percent by weight of collagen. The vehicle or liquid containing collagen can be one of a wide variety of materials, including: alcohols such as methanol; aqueous solutions of perfluoroacids, as shown in US. Patent Nos. 2,919,998 and 2,919,999; and aqueous cyanoacetic acid. Particularly preferred herein are collagen dispersions in a mixture of methanol and aqueous cyanoacetic acid.
The non-absorbable fabric, as in film or mesh form, can be coated with collagen by a number of techniques. The fabric can be immersed in a collagen dispersion for a suitable period of time, and the fabric can then be removed and allowed to drain and dry. Collagen is neutralized after the coated fabric is dry. Alternatively, a dispersion of collagen can be sprayed onto the fabric, followed by draining of the sprayed fabric.
When the fabric is immersed in a collagen dispersion, the fabric is coated with collagen and is thereafter treated to remove collagen present in the pores thereof. This is accomplished advantageously by directing a stream of inert gas against the coated fabric, particularly through the coated fabric. The stream is so adjusted that collagen held in the pores of the coated fabric is removed, while collagen coating the fabric structure is retained. There is little danger that the collagen coat will be removed from the fabric, since a relatively strong bonding of collagen and the fabric obtains. Representative of inert gases useful herein are air, nitrogen, and carbon dioxide. Since air is inexpensive and advantageous, it is preferred.
Still other techniques can be used herein. A fabric treated with collagen can be dried and then perforated to remove collagen from the pores thereof.
Temperatures of the impregnation step, draining (if such is used), neutralization and removal of collagen from the pores, are generally below about C. in each operation to avoid extensive degradation of collagen. Preferred for each operation are temperatures below about 25 C.
It is to be understood that any of the known tanning agents for use with collagen can be used herein. Chromium, formaldehyde, polyhydroxyphenols, etc. can be used alone or in combination. Particularly preferred, however, are the tanning procedures described in related applications Serial Numbers 85,289 and 85,302, both filed January 27, 1961.
In conjunction with the process for coating a nonabsorbable fabric with collagen, it has been discovered that a firmer bonding of collagen and the fabric results when the fabric is pretreated. The pretreatment involves successive contact with a solvent (A) for hydrophilic materials and a solvent (B) for hydrophobic materials. Solvents (A) and (B) are those which do not dissolve or attack the fiber. Solvents falling within category (A) include water and dilute aqueous solutions containing a detergent, among which are sulfates such as sodium lauryl sulfate, sulfonates such as sodium dodecyl benzene sulfonate, phosphates such as sodium tripolyphosphate, polyoxyalkylene derivatives of a hydroxy compound such as a condensate of 1 mol of nonyl phenol with 9 mols of ethylene oxide, quarternary ammonium compounds such as cetyltrimethylammonium chloride, etc. Representative of solvents (B) are: alcohols, typified by methyl, ethyl, n-propyl, isopropyl, n-butyl, secondaryand tertiary-butyl, etc.; ketones, typified by acetone, methyl ethyl, methyl n-propyl, diethyl, etc.; ethers, typified by dimethyl, diethyl, ethyl methyl, etc. Generally, a large excess of one or more solvents (A) and of one or more solvents (B), is used in the pretreatment of a non-adsorbable fiber. Pretreatment is conducted at temperatures from about C. to about 100 C., for time intervals ranging from about 60 minutes to about 1 minute with each solvent, (A) and (B); preferred conditions are the approximate ranges of 6070 C., for 10-5 minutes.
The present invention is more fully described and exemplified in the following examples. It is to be understood, however, that my invention is not to be limited to any specific form or materials or construction set forth in the examples, but is limited solely by the description in this Specification and the appended claims. Throughout the Specification and the examples which follow, all
quantities are expressed in parts by weight unless otherwise indicated.
Example I 4.33 grams of Dacron mesh (40 denier multifilament Dacron 12.5 inch square) was immersed in a gel prepared by diluting a collagen dispersion comprising 0.8 part of collagen, 0.4 part cyanoacetic acid, 49.4 parts water and 49.4 parts of methyl alcohol with an equal volume of methyl alcohol at room temperature (20 C.). The mesh was removed from the dispersion and allowed to drain vertically for about five minutes at room temperature. Compressed air was blown through the mesh to remove any collagenous film remaining across the interstices. If the orifice pressure is about 20 lbs. and the orifice is 4 mm. in diameter, a distance of approximately 3" between the orifice and the mesh is advantageous. Using the same orifice at 35 lbs. pressure, approximately 12" is advantageous between the orifice and the mesh. Shorter distances or higher pressures were found to blow too much collagen from the mesh while longer distances and lower pressures did not completely remove the collagen dispersion from the interstices. The mesh was allowed to dry for several hours at room temperature. The collagen on the mesh fabric was then neutralized with parts of 10% aqueous ammonia and was tanned with 100 parts formaldehyde (1% aqueous solution). Mesh, so obtained, contains approximately 10% by weight of collagen on the surface of the Dacron fibers. When implanted in the subcutaneous tissue of rats, the coated mesh elicited a greater amount of tissue response and fibroplasia than the uncoated mesh and was more readily incorporated by the host tissue.
Example II A piece of Dacron mesh (the same size and Weight as in Example I) was washed successively with 100 parts of hot water (60 C.), with 100 parts of isopropyl alcohol (25 C.) and 100 parts of acetone (25 C.). It was then dried in the air. The dried mesh was placed in a stainless-steel, Teflon coated tray measuring 15" x 9" x /2" containing a A;" layer of collagen dispersion containing 0.8 part of collagen fibrils and 49.4 parts of methyl alcohol, and 49.4 parts of water and 0.4 part of cyanoacetic acid, and another A2" layer of the same dispersion was placed on top of the fabric. The collagen dispersions and mesh were in contact for 24 hours at 25 C. The resulting laminate then was neutralized with 100 parts of 10 percent aqueous ammonia. It was tanned with 100 parts of formaldehyde (1 percent) and removed from the tray. Edges of the mesh were trimmed to remove excess collagen. The laminate was strong, uniform and very resistant to separation. These characteristics continued when the film was wet with water. Only very severe stretching or deformation freed an edge of the collagen from the Dacron mesh and, once freed, it resisted further delarnination.
It is found that Dacron and collagen are more firmly bound by virtue of the pretreatment of Dacron, than when the pretreatment is omitted. In fact, pretreated Dacron and collagen are more firmly bound than when brought together by any other technique.
While the invention has been described in detail according to the articles and manufacture thereof, it is to be understood that changes and modifications can be made (without departing from the spirit or scope of the invention) and it is intended in the appended claims to cover such changes and modifications.
I claim:
1. A surgical prosthesis comprising:
a porous fabric of non-absorbable interlocking fibers;
said fibers being coated with collagen fibrils throughout their area of contact only, whereby the pores 5 of the fabric are open to the rapid ingrowth of body tissue through the prosthesis.
2. The surgical prosthesis of claim 1 wherein the porous fabric is tubular in form.
3. The surgical prosthesis of claim 1 wherein the porous fabric is a synthetic material made from terephthalic acid and ethylene glycol.
4. The surgical prosthesis of claim 1 wherein the porous fabric is a synthetic material made of a tetrafluoroethylene polymer.
References Cited by the Examiner UNITED STATES PATENTS RICHARD A. GAUDET, Primary Examiner.
DALTON L. TRULUCK, Examiner.

Claims (1)

1. A SURGICAL PROSTHESIS COMPRISING: A POROUS FABRIC OF NON-ABSORBABLE INTERLOCKING FIBERS; SAID FIBERS BEING COATED WITH COLLAGEN FIBRILS THROUGHOUT THEIR AREA OF CONTACT ONLY, WHEREBY THE PORES OF THE FABRIC ARE OPEN TO THE RAPID INGROWTH OF BODY TISSUE THROUGH THE PROSTHESIS.
US244600A 1962-12-14 1962-12-14 Collagen coated fabric prosthesis Expired - Lifetime US3276448A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US244600A US3276448A (en) 1962-12-14 1962-12-14 Collagen coated fabric prosthesis
GB49207/63A GB1062876A (en) 1962-12-14 1963-12-12 Surgical prosthesis
SE13929/63A SE314159B (en) 1962-12-14 1963-12-13

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US244600A US3276448A (en) 1962-12-14 1962-12-14 Collagen coated fabric prosthesis

Publications (1)

Publication Number Publication Date
US3276448A true US3276448A (en) 1966-10-04

Family

ID=22923405

Family Applications (1)

Application Number Title Priority Date Filing Date
US244600A Expired - Lifetime US3276448A (en) 1962-12-14 1962-12-14 Collagen coated fabric prosthesis

Country Status (3)

Country Link
US (1) US3276448A (en)
GB (1) GB1062876A (en)
SE (1) SE314159B (en)

Cited By (89)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3366440A (en) * 1964-11-03 1968-01-30 Ethicon Inc Process for manufacturing a collagen fabric-film laminate
US3400719A (en) * 1963-06-11 1968-09-10 Albert O.L.J. Eckhart Buddecke Plastic graft material and method of making same
US3443261A (en) * 1967-09-01 1969-05-13 Fmc Corp Prosthetic structures from microcrystalline collagen
US3463158A (en) * 1963-10-31 1969-08-26 American Cyanamid Co Polyglycolic acid prosthetic devices
US3649347A (en) * 1966-05-27 1972-03-14 Fmc Corp Shaped structures having a self-adherent coating of a water-insoluble ionizable salt of a collagen
US3896806A (en) * 1971-01-08 1975-07-29 Ceskoslovenska Akademie Ved Implant for directed infusion of biologically active substances
EP0000949A1 (en) * 1977-08-26 1979-03-07 Philip Nicholas Sawyer Cardiac and vascular prostheses and methods of making the same
US4329743A (en) * 1979-04-27 1982-05-18 College Of Medicine And Dentistry Of New Jersey Bio-absorbable composite tissue scaffold
US4361552A (en) * 1980-09-26 1982-11-30 Board Of Regents, The University Of Texas System Wound dressing
FR2510394A1 (en) * 1981-07-30 1983-02-04 Ceraver Ligament or tendon prosthesis stimulating tissue regrowth - comprises fibrous material, e.g. carbon fibres, coated with collagen
US4411027A (en) * 1979-04-27 1983-10-25 University Of Medicine And Dentistry Of New Jersey Bio-absorbable composite tissue scaffold
US4512761A (en) * 1981-08-14 1985-04-23 Bentley Laboratories, Inc. Body implantable connector
US4512038A (en) * 1979-04-27 1985-04-23 University Of Medicine And Dentistry Of New Jersey Bio-absorbable composite tissue scaffold
US4584722A (en) * 1982-05-24 1986-04-29 Yeda Research And Development Co., Ltd. Prosthetic tendon
US4629459A (en) * 1983-12-28 1986-12-16 Shiley Inc. Alternate stent covering for tissue valves
EP0206025A2 (en) * 1985-06-06 1986-12-30 Thomas Jefferson University Coating for prosthetic devices
US4759748A (en) * 1986-06-30 1988-07-26 Raychem Corporation Guiding catheter
US4772285A (en) * 1984-05-09 1988-09-20 The Board Of Trustees Of The Leland Stanford Junior University Collagen coated soft tissue prostheses
US4820626A (en) * 1985-06-06 1989-04-11 Thomas Jefferson University Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself
US4822361A (en) * 1985-12-24 1989-04-18 Sumitomo Electric Industries, Ltd. Tubular prosthesis having a composite structure
US4839215A (en) * 1986-06-09 1989-06-13 Ceramed Corporation Biocompatible particles and cloth-like article made therefrom
US4865031A (en) * 1985-07-12 1989-09-12 Keeffe Paul J O Fabric and method of use for treatment of scars
US4915893A (en) * 1982-07-16 1990-04-10 Medtronic, Inc. Method of preparing polyester filament material
AU598470B2 (en) * 1985-07-12 1990-06-28 O'Keeffe, Paul J. Dr. Subdermal mesh for scars
US5037656A (en) * 1986-12-04 1991-08-06 Millipore Corporation Porous membrane having hydrophilic and cell growth promotions surface and process
WO1992000110A1 (en) * 1990-06-25 1992-01-09 W.L. Gore & Associates, Inc. Carvable implant material
US5110852A (en) * 1982-07-16 1992-05-05 Rijksuniversiteit Te Groningen Filament material polylactide mixtures
US5157111A (en) * 1991-05-02 1992-10-20 Pachence James M Method of bonding collagen to fibers, particularly dacron
US5230693A (en) * 1985-06-06 1993-07-27 Thomas Jefferson University Implantable prosthetic device for implantation into a human patient having a surface treated with microvascular endothelial cells
US5383897A (en) * 1992-10-19 1995-01-24 Shadyside Hospital Method and apparatus for closing blood vessel punctures
US5447966A (en) * 1988-07-19 1995-09-05 United States Surgical Corporation Treating bioabsorbable surgical articles by coating with glycerine, polalkyleneoxide block copolymer and gelatin
EP0698395A1 (en) * 1994-08-12 1996-02-28 Meadox Medicals, Inc. Tubular polyetrafluoroethylene implantable prosthesis
DE19517754C1 (en) * 1995-02-02 1996-04-25 Rainer H Frey Biocompatible porous hollow polyolefin fibres used as exchange materials and semipermeable membranes
US5542594A (en) * 1993-10-06 1996-08-06 United States Surgical Corporation Surgical stapling apparatus with biocompatible surgical fabric
US5569239A (en) * 1990-06-15 1996-10-29 Rare Earth Medical, Inc. Photoreactive suturing of biological materials
US5681657A (en) * 1995-02-02 1997-10-28 Rainer H. Frey Biocompatible porous hollow fiber and method of manufacture and use thereof
US5795584A (en) * 1993-01-27 1998-08-18 United States Surgical Corporation Post-surgical anti-adhesion device
US5891167A (en) * 1996-06-19 1999-04-06 United States Surgical Corporation Collagen coated gut suture
US5954748A (en) * 1996-07-15 1999-09-21 United States Surgical Corporation Gelatin coated gut suture
US5998024A (en) * 1995-02-02 1999-12-07 Rainer H. Frey Biocompatible material and method of manufacture and use thereof
US6129757A (en) * 1998-05-18 2000-10-10 Scimed Life Systems Implantable members for receiving therapeutically useful compositions
US6273897B1 (en) 2000-02-29 2001-08-14 Ethicon, Inc. Surgical bettress and surgical stapling apparatus
US6325810B1 (en) 1999-06-30 2001-12-04 Ethicon, Inc. Foam buttress for stapling apparatus
US6387104B1 (en) 1999-11-12 2002-05-14 Scimed Life Systems, Inc. Method and apparatus for endoscopic repair of the lower esophageal sphincter
US6391052B2 (en) 1994-04-29 2002-05-21 Scimed Life Systems, Inc. Stent with collagen
US20040254589A1 (en) * 2001-11-19 2004-12-16 Thierry Darnis Device for occlusion of a corporeal duct, in particular a varicose vein
US20050033362A1 (en) * 2001-09-13 2005-02-10 Grafton R. Donald High strength suture with collagen fibers
US20080051834A1 (en) * 2006-08-28 2008-02-28 Mazzocca Augustus D High strength suture coated with collagen
US20080195202A1 (en) * 2007-02-12 2008-08-14 Lauritzen Nels J Methods for Collagen Processing and Products Using Processed Collagen
US20080260794A1 (en) * 2007-02-12 2008-10-23 Lauritzen Nels J Collagen products and methods for producing collagen products
US7614258B2 (en) 2006-10-19 2009-11-10 C.R. Bard, Inc. Prosthetic repair fabric
EP1028672B2 (en) 1997-11-07 2011-08-03 Expandable Grafts Partnership Intravascular stent and method for manufacturing an intravascular stent
US8460691B2 (en) 2010-04-23 2013-06-11 Warsaw Orthopedic, Inc. Fenestrated wound repair scaffold
US8790699B2 (en) 2010-04-23 2014-07-29 Warsaw Orthpedic, Inc. Foam-formed collagen strand
US9005308B2 (en) 2011-10-25 2015-04-14 Covidien Lp Implantable film/mesh composite for passage of tissue therebetween
US9242026B2 (en) 2008-06-27 2016-01-26 Sofradim Production Biosynthetic implant for soft tissue repair
US9308068B2 (en) 2007-12-03 2016-04-12 Sofradim Production Implant for parastomal hernia
US9445883B2 (en) 2011-12-29 2016-09-20 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US9499927B2 (en) 2012-09-25 2016-11-22 Sofradim Production Method for producing a prosthesis for reinforcing the abdominal wall
US9510927B2 (en) 2012-06-28 2016-12-06 Sofradim Production Method of making a knit with barbs
US9526603B2 (en) 2011-09-30 2016-12-27 Covidien Lp Reversible stiffening of light weight mesh
US9554887B2 (en) 2011-03-16 2017-01-31 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US9622843B2 (en) 2011-07-13 2017-04-18 Sofradim Production Umbilical hernia prosthesis
WO2017087676A1 (en) 2015-11-19 2017-05-26 Tepha, Inc. Methods to produce perforated collagen coated surgical meshes
US9750837B2 (en) 2012-09-25 2017-09-05 Sofradim Production Haemostatic patch and method of preparation
US9801705B2 (en) 2012-06-29 2017-10-31 Sofradim Production Hernia prosthesis
US9839505B2 (en) 2012-09-25 2017-12-12 Sofradim Production Prosthesis comprising a mesh and a strengthening means
US9877820B2 (en) 2014-09-29 2018-01-30 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US9931198B2 (en) 2015-04-24 2018-04-03 Sofradim Production Prosthesis for supporting a breast structure
US9932695B2 (en) 2014-12-05 2018-04-03 Sofradim Production Prosthetic porous knit
US9980802B2 (en) 2011-07-13 2018-05-29 Sofradim Production Umbilical hernia prosthesis
US10076395B2 (en) 2010-07-16 2018-09-18 Sofradim Production Prosthesis having a radiopaque element
US10080639B2 (en) 2011-12-29 2018-09-25 Sofradim Production Prosthesis for inguinal hernia
US10159555B2 (en) 2012-09-28 2018-12-25 Sofradim Production Packaging for a hernia repair device
US10184032B2 (en) 2015-02-17 2019-01-22 Sofradim Production Method for preparing a chitosan-based matrix comprising a fiber reinforcement member
US10206769B2 (en) 2012-03-30 2019-02-19 Covidien Lp Implantable devices including a film providing folding characteristics
US10213283B2 (en) 2013-06-07 2019-02-26 Sofradim Production Textile-based prosthesis for laparoscopic surgery
US10327882B2 (en) 2014-09-29 2019-06-25 Sofradim Production Whale concept—folding mesh for TIPP procedure for inguinal hernia
US10363690B2 (en) 2012-08-02 2019-07-30 Sofradim Production Method for preparing a chitosan-based porous layer
US10405960B2 (en) 2013-06-07 2019-09-10 Sofradim Production Textile-based prothesis for laparoscopic surgery
US10549015B2 (en) 2014-09-24 2020-02-04 Sofradim Production Method for preparing an anti-adhesion barrier film
US10576187B2 (en) 2016-03-15 2020-03-03 University of Pittsburgh—of the Commonwealth System of Higher Education Layer by layer coated mesh for local release of bio-active proteins
US10646321B2 (en) 2016-01-25 2020-05-12 Sofradim Production Prosthesis for hernia repair
US10675137B2 (en) 2017-05-02 2020-06-09 Sofradim Production Prosthesis for inguinal hernia repair
US10682215B2 (en) 2016-10-21 2020-06-16 Sofradim Production Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained
US10743976B2 (en) 2015-06-19 2020-08-18 Sofradim Production Synthetic prosthesis comprising a knit and a non porous film and method for forming same
US10865505B2 (en) 2009-09-04 2020-12-15 Sofradim Production Gripping fabric coated with a bioresorbable impenetrable layer
CN113481644A (en) * 2021-06-03 2021-10-08 王剑 Moisture-absorbing and heat-insulating gold-stamping fabric and preparation method thereof
US11471257B2 (en) 2018-11-16 2022-10-18 Sofradim Production Implants suitable for soft tissue repair

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2704139B1 (en) * 1993-04-23 1995-08-04 Jean Claude Sgro PROSTHETIC ASSEMBLY IN TEXTILE MATERIAL.

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1514548A (en) * 1921-09-10 1924-11-04 Lionne Ernest Porous impregnated fabric
US2039262A (en) * 1933-02-11 1936-04-28 Koninklijke Pharma Fab Nv Process for the manufacture of threads, strings, bands, films, and the like
US2305006A (en) * 1939-02-08 1942-12-15 Robert S Holt Method of delustering textile material and resulting product
US3106483A (en) * 1961-07-27 1963-10-08 Us Catheter & Instr Corp Synthetic blood vessel grafts

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1514548A (en) * 1921-09-10 1924-11-04 Lionne Ernest Porous impregnated fabric
US2039262A (en) * 1933-02-11 1936-04-28 Koninklijke Pharma Fab Nv Process for the manufacture of threads, strings, bands, films, and the like
US2305006A (en) * 1939-02-08 1942-12-15 Robert S Holt Method of delustering textile material and resulting product
US3106483A (en) * 1961-07-27 1963-10-08 Us Catheter & Instr Corp Synthetic blood vessel grafts

Cited By (142)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3400719A (en) * 1963-06-11 1968-09-10 Albert O.L.J. Eckhart Buddecke Plastic graft material and method of making same
US3463158A (en) * 1963-10-31 1969-08-26 American Cyanamid Co Polyglycolic acid prosthetic devices
US3366440A (en) * 1964-11-03 1968-01-30 Ethicon Inc Process for manufacturing a collagen fabric-film laminate
US3649347A (en) * 1966-05-27 1972-03-14 Fmc Corp Shaped structures having a self-adherent coating of a water-insoluble ionizable salt of a collagen
US3443261A (en) * 1967-09-01 1969-05-13 Fmc Corp Prosthetic structures from microcrystalline collagen
US3896806A (en) * 1971-01-08 1975-07-29 Ceskoslovenska Akademie Ved Implant for directed infusion of biologically active substances
EP0000949A1 (en) * 1977-08-26 1979-03-07 Philip Nicholas Sawyer Cardiac and vascular prostheses and methods of making the same
US4167045A (en) * 1977-08-26 1979-09-11 Interface Biomedical Laboratories Corp. Cardiac and vascular prostheses
US4329743A (en) * 1979-04-27 1982-05-18 College Of Medicine And Dentistry Of New Jersey Bio-absorbable composite tissue scaffold
US4411027A (en) * 1979-04-27 1983-10-25 University Of Medicine And Dentistry Of New Jersey Bio-absorbable composite tissue scaffold
US4512038A (en) * 1979-04-27 1985-04-23 University Of Medicine And Dentistry Of New Jersey Bio-absorbable composite tissue scaffold
US4361552A (en) * 1980-09-26 1982-11-30 Board Of Regents, The University Of Texas System Wound dressing
FR2510394A1 (en) * 1981-07-30 1983-02-04 Ceraver Ligament or tendon prosthesis stimulating tissue regrowth - comprises fibrous material, e.g. carbon fibres, coated with collagen
US4512761A (en) * 1981-08-14 1985-04-23 Bentley Laboratories, Inc. Body implantable connector
US4584722A (en) * 1982-05-24 1986-04-29 Yeda Research And Development Co., Ltd. Prosthetic tendon
US5110852A (en) * 1982-07-16 1992-05-05 Rijksuniversiteit Te Groningen Filament material polylactide mixtures
US4915893A (en) * 1982-07-16 1990-04-10 Medtronic, Inc. Method of preparing polyester filament material
US4629459A (en) * 1983-12-28 1986-12-16 Shiley Inc. Alternate stent covering for tissue valves
US4772285A (en) * 1984-05-09 1988-09-20 The Board Of Trustees Of The Leland Stanford Junior University Collagen coated soft tissue prostheses
EP0206025A2 (en) * 1985-06-06 1986-12-30 Thomas Jefferson University Coating for prosthetic devices
AU590573B2 (en) * 1985-06-06 1989-11-09 Thomas Jefferson University Coating for prosthetic devices
US5230693A (en) * 1985-06-06 1993-07-27 Thomas Jefferson University Implantable prosthetic device for implantation into a human patient having a surface treated with microvascular endothelial cells
EP0206025A3 (en) * 1985-06-06 1988-03-02 Thomas Jefferson University Coating for prosthetic devices
US4820626A (en) * 1985-06-06 1989-04-11 Thomas Jefferson University Method of treating a synthetic or naturally occuring surface with microvascular endothelial cells, and the treated surface itself
AU598470B2 (en) * 1985-07-12 1990-06-28 O'Keeffe, Paul J. Dr. Subdermal mesh for scars
US4865031A (en) * 1985-07-12 1989-09-12 Keeffe Paul J O Fabric and method of use for treatment of scars
US4822361A (en) * 1985-12-24 1989-04-18 Sumitomo Electric Industries, Ltd. Tubular prosthesis having a composite structure
US4839215A (en) * 1986-06-09 1989-06-13 Ceramed Corporation Biocompatible particles and cloth-like article made therefrom
US4759748A (en) * 1986-06-30 1988-07-26 Raychem Corporation Guiding catheter
US5037656A (en) * 1986-12-04 1991-08-06 Millipore Corporation Porous membrane having hydrophilic and cell growth promotions surface and process
US5447966A (en) * 1988-07-19 1995-09-05 United States Surgical Corporation Treating bioabsorbable surgical articles by coating with glycerine, polalkyleneoxide block copolymer and gelatin
US5569239A (en) * 1990-06-15 1996-10-29 Rare Earth Medical, Inc. Photoreactive suturing of biological materials
WO1992000110A1 (en) * 1990-06-25 1992-01-09 W.L. Gore & Associates, Inc. Carvable implant material
US5098779A (en) * 1990-06-25 1992-03-24 W. L. Gore & Associates, Inc. Carvable implant material
US5157111A (en) * 1991-05-02 1992-10-20 Pachence James M Method of bonding collagen to fibers, particularly dacron
US5383897A (en) * 1992-10-19 1995-01-24 Shadyside Hospital Method and apparatus for closing blood vessel punctures
US5795584A (en) * 1993-01-27 1998-08-18 United States Surgical Corporation Post-surgical anti-adhesion device
US6045560A (en) * 1993-10-06 2000-04-04 United States Surgical Corporation Surgical stapling apparatus with biocompatible surgical fabric
US5964774A (en) * 1993-10-06 1999-10-12 United States Surgical Corporation Surgical stapling apparatus and method with surgical fabric
US5908427A (en) * 1993-10-06 1999-06-01 United States Surgical Corporation Surgical stapling apparatus and method
US5542594A (en) * 1993-10-06 1996-08-06 United States Surgical Corporation Surgical stapling apparatus with biocompatible surgical fabric
US6391052B2 (en) 1994-04-29 2002-05-21 Scimed Life Systems, Inc. Stent with collagen
US5716660A (en) * 1994-08-12 1998-02-10 Meadox Medicals, Inc. Tubular polytetrafluoroethylene implantable prostheses
US5665114A (en) * 1994-08-12 1997-09-09 Meadox Medicals, Inc. Tubular expanded polytetrafluoroethylene implantable prostheses
EP0698395A1 (en) * 1994-08-12 1996-02-28 Meadox Medicals, Inc. Tubular polyetrafluoroethylene implantable prosthesis
JPH0866468A (en) * 1994-08-12 1996-03-12 Meadox Medicals Inc Implantable tubular prosthesis made of polytetrafluoroethylene
US5681657A (en) * 1995-02-02 1997-10-28 Rainer H. Frey Biocompatible porous hollow fiber and method of manufacture and use thereof
US5817272A (en) * 1995-02-02 1998-10-06 Rainer H. Frey Process for making a biocompatible porous holllow fiber
US5863654A (en) * 1995-02-02 1999-01-26 Rainer H. Frey Biocompatible porous hollow fiber and method of manufacture and use thereof
DE19517727C1 (en) * 1995-02-02 1996-04-25 Rainer H Frey Biocompatible polyolefin materials
DE19517754C1 (en) * 1995-02-02 1996-04-25 Rainer H Frey Biocompatible porous hollow polyolefin fibres used as exchange materials and semipermeable membranes
US5998024A (en) * 1995-02-02 1999-12-07 Rainer H. Frey Biocompatible material and method of manufacture and use thereof
US5891167A (en) * 1996-06-19 1999-04-06 United States Surgical Corporation Collagen coated gut suture
US5954748A (en) * 1996-07-15 1999-09-21 United States Surgical Corporation Gelatin coated gut suture
EP1028672B2 (en) 1997-11-07 2011-08-03 Expandable Grafts Partnership Intravascular stent and method for manufacturing an intravascular stent
US6129757A (en) * 1998-05-18 2000-10-10 Scimed Life Systems Implantable members for receiving therapeutically useful compositions
US6325810B1 (en) 1999-06-30 2001-12-04 Ethicon, Inc. Foam buttress for stapling apparatus
US6387104B1 (en) 1999-11-12 2002-05-14 Scimed Life Systems, Inc. Method and apparatus for endoscopic repair of the lower esophageal sphincter
US9247939B2 (en) 1999-11-12 2016-02-02 Boston Scientific Scimed, Inc. Methods and devices for manipulating tissue
US6837894B2 (en) 1999-11-12 2005-01-04 Scimed Life Systems, Inc. Method and apparatus for endoscopic repair of the lower esophageal sphincter
US20050149074A1 (en) * 1999-11-12 2005-07-07 Scimed Life Systems, Inc. Apparatus for endoscopic repair of the lower esophageal sphincter
US8628543B2 (en) 1999-11-12 2014-01-14 Boston Scientific Scimed, Inc. Method and apparatus for endoscopic repair of the lower esophageal sphincter
US7918864B2 (en) 1999-11-12 2011-04-05 Boston Scientific Scimed, Inc. Apparatus for endoscopic repair of the lower esophageal sphincter
US20110208219A1 (en) * 1999-11-12 2011-08-25 Boston Scientific Scimed, Inc. Method and apparatus for endoscopic repair of the lower esophageal sphincter
US6273897B1 (en) 2000-02-29 2001-08-14 Ethicon, Inc. Surgical bettress and surgical stapling apparatus
US20050033362A1 (en) * 2001-09-13 2005-02-10 Grafton R. Donald High strength suture with collagen fibers
US8100934B2 (en) * 2001-11-19 2012-01-24 Sofradim Production Device for occlusion of a corporeal duct, in particular a varicose vein
US20040254589A1 (en) * 2001-11-19 2004-12-16 Thierry Darnis Device for occlusion of a corporeal duct, in particular a varicose vein
US20080051834A1 (en) * 2006-08-28 2008-02-28 Mazzocca Augustus D High strength suture coated with collagen
US9186432B2 (en) 2006-08-28 2015-11-17 Arthrex, Inc. High strength suture coated with collagen
US7614258B2 (en) 2006-10-19 2009-11-10 C.R. Bard, Inc. Prosthetic repair fabric
US7900484B2 (en) 2006-10-19 2011-03-08 C.R. Bard, Inc. Prosthetic repair fabric
US20080260794A1 (en) * 2007-02-12 2008-10-23 Lauritzen Nels J Collagen products and methods for producing collagen products
US20080195202A1 (en) * 2007-02-12 2008-08-14 Lauritzen Nels J Methods for Collagen Processing and Products Using Processed Collagen
US9056151B2 (en) 2007-02-12 2015-06-16 Warsaw Orthopedic, Inc. Methods for collagen processing and products using processed collagen
US10368971B2 (en) 2007-12-03 2019-08-06 Sofradim Production Implant for parastomal hernia
US9308068B2 (en) 2007-12-03 2016-04-12 Sofradim Production Implant for parastomal hernia
US9242026B2 (en) 2008-06-27 2016-01-26 Sofradim Production Biosynthetic implant for soft tissue repair
US10070948B2 (en) 2008-06-27 2018-09-11 Sofradim Production Biosynthetic implant for soft tissue repair
US10865505B2 (en) 2009-09-04 2020-12-15 Sofradim Production Gripping fabric coated with a bioresorbable impenetrable layer
US9771410B2 (en) 2010-04-23 2017-09-26 Warsaw Orthopedic, Inc. Foam-formed collagen strand
US8790699B2 (en) 2010-04-23 2014-07-29 Warsaw Orthpedic, Inc. Foam-formed collagen strand
US8460691B2 (en) 2010-04-23 2013-06-11 Warsaw Orthopedic, Inc. Fenestrated wound repair scaffold
US10076395B2 (en) 2010-07-16 2018-09-18 Sofradim Production Prosthesis having a radiopaque element
US11612472B2 (en) 2011-03-16 2023-03-28 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US10472750B2 (en) 2011-03-16 2019-11-12 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US9554887B2 (en) 2011-03-16 2017-01-31 Sofradim Production Prosthesis comprising a three-dimensional and openworked knit
US11039912B2 (en) 2011-07-13 2021-06-22 Sofradim Production Umbilical hernia prosthesis
US10709538B2 (en) 2011-07-13 2020-07-14 Sofradim Production Umbilical hernia prosthesis
US11903807B2 (en) 2011-07-13 2024-02-20 Sofradim Production Umbilical hernia prosthesis
US9980802B2 (en) 2011-07-13 2018-05-29 Sofradim Production Umbilical hernia prosthesis
US9622843B2 (en) 2011-07-13 2017-04-18 Sofradim Production Umbilical hernia prosthesis
US9526603B2 (en) 2011-09-30 2016-12-27 Covidien Lp Reversible stiffening of light weight mesh
US9005308B2 (en) 2011-10-25 2015-04-14 Covidien Lp Implantable film/mesh composite for passage of tissue therebetween
US11471256B2 (en) 2011-12-29 2022-10-18 Sofradim Production Prosthesis for inguinal hernia
US11266489B2 (en) 2011-12-29 2022-03-08 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US9445883B2 (en) 2011-12-29 2016-09-20 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US11925543B2 (en) 2011-12-29 2024-03-12 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US10080639B2 (en) 2011-12-29 2018-09-25 Sofradim Production Prosthesis for inguinal hernia
US10342652B2 (en) 2011-12-29 2019-07-09 Sofradim Production Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit
US10206769B2 (en) 2012-03-30 2019-02-19 Covidien Lp Implantable devices including a film providing folding characteristics
US9510927B2 (en) 2012-06-28 2016-12-06 Sofradim Production Method of making a knit with barbs
US9801705B2 (en) 2012-06-29 2017-10-31 Sofradim Production Hernia prosthesis
US10363690B2 (en) 2012-08-02 2019-07-30 Sofradim Production Method for preparing a chitosan-based porous layer
US9839505B2 (en) 2012-09-25 2017-12-12 Sofradim Production Prosthesis comprising a mesh and a strengthening means
US9499927B2 (en) 2012-09-25 2016-11-22 Sofradim Production Method for producing a prosthesis for reinforcing the abdominal wall
US9750837B2 (en) 2012-09-25 2017-09-05 Sofradim Production Haemostatic patch and method of preparation
US10159555B2 (en) 2012-09-28 2018-12-25 Sofradim Production Packaging for a hernia repair device
US10213283B2 (en) 2013-06-07 2019-02-26 Sofradim Production Textile-based prosthesis for laparoscopic surgery
US11304790B2 (en) 2013-06-07 2022-04-19 Sofradim Production Textile-based prothesis for laparoscopic surgery
US11622845B2 (en) 2013-06-07 2023-04-11 Sofradim Production Textile-based prothesis for laparoscopic surgery
US10405960B2 (en) 2013-06-07 2019-09-10 Sofradim Production Textile-based prothesis for laparoscopic surgery
US10549015B2 (en) 2014-09-24 2020-02-04 Sofradim Production Method for preparing an anti-adhesion barrier film
US10653508B2 (en) 2014-09-29 2020-05-19 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US11291536B2 (en) 2014-09-29 2022-04-05 Sofradim Production Whale concept-folding mesh for TIPP procedure for inguinal hernia
US11589974B2 (en) 2014-09-29 2023-02-28 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US10327882B2 (en) 2014-09-29 2019-06-25 Sofradim Production Whale concept—folding mesh for TIPP procedure for inguinal hernia
US9877820B2 (en) 2014-09-29 2018-01-30 Sofradim Production Textile-based prosthesis for treatment of inguinal hernia
US11359313B2 (en) 2014-12-05 2022-06-14 Sofradim Production Prosthetic porous knit
US10745835B2 (en) 2014-12-05 2020-08-18 Sofradim Production Prosthetic porous knit
US9932695B2 (en) 2014-12-05 2018-04-03 Sofradim Production Prosthetic porous knit
US11713526B2 (en) 2014-12-05 2023-08-01 Sofradim Production Prosthetic porous knit
US10815345B2 (en) 2015-02-17 2020-10-27 Sofradim Production Method for preparing a chitosan-based matrix comprising a fiber reinforcement member
US10184032B2 (en) 2015-02-17 2019-01-22 Sofradim Production Method for preparing a chitosan-based matrix comprising a fiber reinforcement member
US11439498B2 (en) 2015-04-24 2022-09-13 Sofradim Production Prosthesis for supporting a breast structure
US10660741B2 (en) 2015-04-24 2020-05-26 Sofradim Production Prosthesis for supporting a breast structure
US9931198B2 (en) 2015-04-24 2018-04-03 Sofradim Production Prosthesis for supporting a breast structure
US10743976B2 (en) 2015-06-19 2020-08-18 Sofradim Production Synthetic prosthesis comprising a knit and a non porous film and method for forming same
US11826242B2 (en) 2015-06-19 2023-11-28 Sofradim Production Synthetic prosthesis comprising a knit and a non porous film and method for forming same
US10532127B2 (en) 2015-11-19 2020-01-14 Tepha, Inc. Methods to produce perforated collagen coated surgical meshes
WO2017087676A1 (en) 2015-11-19 2017-05-26 Tepha, Inc. Methods to produce perforated collagen coated surgical meshes
US10646321B2 (en) 2016-01-25 2020-05-12 Sofradim Production Prosthesis for hernia repair
US11389282B2 (en) 2016-01-25 2022-07-19 Sofradim Production Prosthesis for hernia repair
US10576187B2 (en) 2016-03-15 2020-03-03 University of Pittsburgh—of the Commonwealth System of Higher Education Layer by layer coated mesh for local release of bio-active proteins
US10888641B2 (en) 2016-03-15 2021-01-12 University of Pittsburgh—of the Commonwealth System of Higher Education Layer by layer coated mesh for local release of bio-active proteins
US11596718B2 (en) 2016-03-15 2023-03-07 University of Pittsburgh—of the Commonwealth System of Higher Education Layer by layer coated mesh for local release of bio-active proteins
US10682215B2 (en) 2016-10-21 2020-06-16 Sofradim Production Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained
US11696819B2 (en) 2016-10-21 2023-07-11 Sofradim Production Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained
US11672636B2 (en) 2017-05-02 2023-06-13 Sofradim Production Prosthesis for inguinal hernia repair
US10675137B2 (en) 2017-05-02 2020-06-09 Sofradim Production Prosthesis for inguinal hernia repair
US11471257B2 (en) 2018-11-16 2022-10-18 Sofradim Production Implants suitable for soft tissue repair
CN113481644A (en) * 2021-06-03 2021-10-08 王剑 Moisture-absorbing and heat-insulating gold-stamping fabric and preparation method thereof

Also Published As

Publication number Publication date
SE314159B (en) 1969-09-01
GB1062876A (en) 1967-03-22

Similar Documents

Publication Publication Date Title
US3276448A (en) Collagen coated fabric prosthesis
EP1173237B1 (en) Expanded polytetrafluoroethylene vascular graft with coating
US3272204A (en) Absorbable collagen prosthetic implant with non-absorbable reinforcing strands
RU2725723C2 (en) Warp knitted fabric and medical material
US3108357A (en) Compound absorbable prosthetic implants, fabrics and yarns therefor
US3986828A (en) Polymer fabric compacting process
JP5280839B2 (en) Absorbable / biodegradable composite yarn and property-adjusting surgical implant formed therefrom
Chu et al. Characterization of morphologic and mechanical properties of surgical mesh fabrics
US20060116696A1 (en) Planar implant and surgical use thereof
US9796769B2 (en) Methods of making bioactive collagen medical scaffolds such as for wound care dressings, hernia repair prosthetics, and surgical incision closure members
US11622892B2 (en) Methods of making bioactive collagen wound care dressings
JP6451646B2 (en) Artificial blood vessel
WO1998037813A1 (en) Fabric prosthesis and process for preparing the same
JPS63209647A (en) Artificial blood vessel
US3284557A (en) Process for crimping an artificial implant for use in an animal body
JP4583927B2 (en) Tissue support prosthesis
JPS6158190B2 (en)
King et al. Evaluating the dialine® vascular prosthesis knitted from an alternative source of polyester yarns
JPS632620B2 (en)
JPH04250167A (en) Medical prosthesis material
CA2716141A1 (en) Coatings that enhance resistance to abrasion
US20170002511A1 (en) Hydrogelling fibers and fiber structures
JPS61238238A (en) Production of artificial blood vessel
CN216724875U (en) Artificial patch
WO2000018321A1 (en) Hydrophilic synthetic blood vessels